Pearl of the Month

Not your ordinary neuropathy


 

Pearl

Strongly consider treatment induced neuropathy in your patients with diabetes who present with acute painful neuropathy and/or autonomic dysfunction in the setting of rapid improvement of glucose control.

Dr. Paauw is professor of medicine in the division of general internal medicine at the University of Washington, Seattle, and serves as third-year medical student clerkship director at the University of Washington. He is a member of the editorial advisory board of Internal Medicine News. Dr. Paauw has no conflicts to disclose. Contact him at imnews@mdedge.com.

References

1. American Diabetes Association. Diabetes Care. 2019 Jan;42(Suppl 1):S90-102.

2. Gibbons CH and Freeman R. Ann Neurol 2010; 67:534–41.

3. Gibbons CH and Freeman R. Brain. 2015;138:43-52.

4. Siddique N et al. Endocrinol Diabetes Metab Case Rep. 2020 Feb 26;2020:19-0140.

Pages

Recommended Reading

Mild cortisol excess increases mortality in adrenal incidentaloma
MDedge Endocrinology
Daily cup of coffee cuts type 2 diabetes risk by about 5%
MDedge Endocrinology
‘Overbasalization’ common in type 2 diabetes management
MDedge Endocrinology
FDA panel endorses teplizumab for delaying type 1 diabetes
MDedge Endocrinology
Semaglutide boosts weight loss following endoscopic gastroplasty
MDedge Endocrinology
‘A better picture’: First AACE guidelines on diabetes technology
MDedge Endocrinology
Pericardial fat an independent risk factor for heart failure
MDedge Endocrinology
Prediabetes linked to higher CVD and CKD rates
MDedge Endocrinology
Dapagliflozin’s cost-effectiveness ‘intermediate’ for HFrEF
MDedge Endocrinology
A1c below prediabetes cutoff linked to subclinical atherosclerosis
MDedge Endocrinology